Synapse Open Synapse
Biology

STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial

STAT News · · 1 min read

Sellas' experimental blood cancer immunotherapy reduced the risk of death in clinical trial.

Latest from STAT News